Distinct response to dioxin in an arylhydrocarbon receptor (AHR)-humanized mouse
Open accessAbstract
There are large inter- and intraspecies differences in susceptibility to dioxin-induced toxicities. A critical question in risk assessment of dioxin and related compounds is whether humans are sensitive or resistant to their toxicities. The diverse responses of mammals to dioxin are strongly influenced by functional polymorphisms of the arylhydrocarbon receptor (AHR). To characterize responses mediated by the human AHR (hAHR), we generated a mouse possessing hAHR instead of mouse AHR. Responses of these mice to 2,3,7,8-tetrachlorodibenzo- p -dioxin (TCDD) and 3-methylcholanthrene were compared with the responses of naturally sensitive (C57BL/6J) and resistant (DBA/2) mice. Mice homozygous for h AHR exhibited weaker induction of AHR target genes such as cyp1a1 and cyp1a2 than did C57BL/6J ( Ahr b-1/b-1 ) mice. DBA/2 ( Ahr d/d ) mice were less responsive to induction of cyp genes than C57BL/6J mice. hAHR and DBA/2 AHR exhibit similar ligand-binding affinities and homozygous h AHR and Ahr d/d mice displayed comparable induction of AHR target genes by 3-methylcholanthrene. However, when TCDD was administered, a greatly diminished response was observed in homozygous h AHR mice compared with Ahr d/d mice, indicating that hAHR expressed in mice is functionally less responsive to TCDD than DBA/2 AHR. After maternal exposure to TCDD, homozygous h AHR fetuses developed embryonic hydronephrosis, but not cleft palate, whereas fetuses possessing Ahr b-1 or Ahr d developed both anomalies. These results suggest that hAHR may define the specificity of the responses to various AHR ligands. Thus, the hAHR knock-in mouse is a humanized model mouse that may better predict the biological effects of bioaccumulative environmental toxicants like TCDD in humans.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The AhrHum allele is less sensitive to TCDD than the Ahrd allele.
“Interestingly, in early reports, the AhrHum allele was shown to be less sensitive to TCDD than the Ahrd allele (Moriguchi et al., 2003).”
From Rodent Genetic Models of Ah Receptor Signaling (2021) · cites this paper as Moriguchi et al., 2003
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Analysis of the four alleles of the murine aryl hydrocarbon receptor
Poland, A., Palen, D., & Glover, E. (1994) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09833-5 · Cited by 303 · see citing works
Flagged first, then by citations
Research works printed but not linked: 34
- [1]Poland A, Knutson C. Annu Rev Pharmacol Toxicol. 1982;22:517–554. doi: 10.1146/annurev.pa.22.040182.002505. [DOI] [PubMed] [Google Scholar] · DOI · Paper page
- [2]Whitelock J P., Jr Annu Rev Pharmacol Toxicol. 1990;30:251–277. doi: 10.1146/annurev.pa.30.040190.001343. [DOI] [PubMed] [Google Scholar] · DOI
- [3]Landers J P, Bunce N J. Biochem J. 1991;276:273–287. doi: 10.1042/bj2760273. [DOI] [PMC free article] [PubMed] [Google Scholar] · DOI
- [4]Swanson H J, Bradfield C A. Pharmacogenetics. 1993;3:213–230. doi: 10.1097/00008571-199310000-00001. [DOI] [PubMed] [Google Scholar] · DOI
- [5]Hoffman E C, Reyes H, Chu F-F, Sander F, Conly L H, Brooks B A, Hankinsin O. Science. 1991;252:954–958. doi: 10.1126/science.1852076. [DOI] [PubMed] [Google Scholar] · DOI
- [6]Okey A B, Riddick D, Harper P A. Toxicol Lett. 1994;70:1–22. doi: 10.1016/0378-4274(94)90139-2. [DOI] [PubMed] [Google Scholar] · DOI
- [7]Rowlands J, Gustafsson J A. CRC Crit Rev Toxicol. 1997;27:109–134. doi: 10.3109/10408449709021615. [DOI] [PubMed] [Google Scholar] · DOI
- [8]Poellinger L. Food Addit Contam. 2000;17:261–266. doi: 10.1080/026520300283333. [DOI] [PubMed] [Google Scholar] · DOI
- [9]Ema M, Ohe N, Suzuki M, Mimura J, Sogawa K, Ikawa S, Fujii-Kuriyama Y. J Biol Chem. 1994;269:27337–27343. [PubMed] [Google Scholar]
- [10]Poland A, Glover E. Mol Pharmacol. 1990;38:306–312. [PubMed] [Google Scholar]
- [11]Poland A, Palen D, Glover E. Mol Pharmacol. 1994;46:915–921. [PubMed] [Google Scholar]
- [12]Ema M, Matsushita N, Sogawa K, Ariyama T, Inazawa J, Nemoto T, Ota M, Oshimura M, Fujii-Kuriyama Y. J Biochem. 1994;116:845–851. doi: 10.1093/oxfordjournals.jbchem.a124605. [DOI] [PubMed] [Google Scholar] · DOI
- [13]Dolwick K M, Schmidt J V, Carver L A, Swanson H I, Bradfield C A. Mol Pharmacol. 1993;44:911–917. [PubMed] [Google Scholar]
- [14]Okey A B, Vella L M, Harper P A. Mol Pharmacol. 1989;35:823–830. [PubMed] [Google Scholar]
- [15]Pohjanvirta R, Unkila M, Tuomisto J. Pharmacol Toxicol. 1993;73:52–56. doi: 10.1111/j.1600-0773.1993.tb01958.x. [DOI] [PubMed] [Google Scholar] · DOI
- [16]Pohjanvirta R, Wong J M Y, Li W, Harper P A, Tuomisto J, Okey A B. Mol Pharmacol. 1998;54:86–93. doi: 10.1124/mol.54.1.86. [DOI] [PubMed] [Google Scholar] · DOI · Paper page
- [17]Tuomisto J T, Viluksela M, Pohjanvirta R, Tuomisto J. Toxicol Appl Pharmacol. 1999;155:71–81. doi: 10.1006/taap.1998.8564. [DOI] [PubMed] [Google Scholar] · DOI
- [18]Mocarelli P, Gerthoux P M, Ferrari E, Patterson D G, Jr, Kieszak S M, Brambilla P, Vincoli N, Signorini S, Tramacre P, Carreri V, et al. Lancet. 2000;355:1858–1863. doi: 10.1016/S0140-6736(00)02290-X. [DOI] [PubMed] [Google Scholar] · DOI
- [19]Micka J, Milatovich A, Menon A, Grabowski G A, Puga A, Nebert D W. Pharmacogenetics. 1997;7:95–101. doi: 10.1097/00008571-199704000-00002. [DOI] [PubMed] [Google Scholar] · DOI
- [20]Kohkalainen M, Tuomisto J, Pohjanvirta R. Biochem Biophys Res Commun. 2001;285:1121–1129. doi: 10.1006/bbrc.2001.5317. [DOI] [PubMed] [Google Scholar] · DOI
- [21]Abnet C C, Tanguay R L, Heideman W, Peterson R E. Toxicol Appl Pharmacol. 1999;159:41–51. doi: 10.1006/taap.1999.8719. [DOI] [PubMed] [Google Scholar] · DOI
- [22]Mimura J, Yamashita K, Nakamura K, Morita M, Takagi T N, Nakao K, Ema M, Sogawa K, Yasuda M, Katsuki M, et al. Genes Cell. 1997;2:645–654. doi: 10.1046/j.1365-2443.1997.1490345.x. [DOI] [PubMed] [Google Scholar] · DOI · Paper page
- [23]Hooper M, Hardy K, Handyside A, Hunter S, Monk M. Nature. 1987;326:292–295. doi: 10.1038/326292a0. [DOI] [PubMed] [Google Scholar] · DOI
- [24]Ema M, Sogawa K, Watanabe N, Chujoh Y, Matsushita N, Gotoh O, Funae Y, Fujii-Kuriyama Y. Biochem Biophys Res Commun. 1992;184:246–253. doi: 10.1016/0006-291x(92)91185-s. [DOI] [PubMed] [Google Scholar] · DOI
- [25]Fernandez-Salguero P, Pineau T, Hilbert D M, McPhail T, Lee S S T, Kimura S, Nebert D W, Rudikoff S, Ward J M, Gonzalez F J. Science. 1995;268:722–726. doi: 10.1126/science.7732381. [DOI] [PubMed] [Google Scholar] · DOI · Paper page
- [26]Moriguchi T, Sakurai T, Takahashi S, Goto K, Yamamoto M. J Biol Chem. 2002;277:16985–16992. doi: 10.1074/jbc.M107962200. [DOI] [PubMed] [Google Scholar] · DOI
- [27]Yasuda M, Igarashi E, Datu A R, Igawa H. Teratology. 1986;34:454–455. [Google Scholar]
- [28]Birnbaum L S, Harris M W, Barnhart E R, Morrissey R E. Toxicol Appl Pharmacol. 1987;90:206–216. doi: 10.1016/0041-008x(87)90328-0. [DOI] [PubMed] [Google Scholar] · DOI
- [29]Birnbaum L S, Abbott B. In: Methods in Developmental Toxicology and Biology. Klug S, Thiel R, editors. London: Blackwell Science; 1997. pp. 51–63. [Google Scholar]
- [30]Tsai F Y, Browne C P B, Orkin S H. Dev Biol. 1998;196:218–227. doi: 10.1006/dbio.1997.8842. [DOI] [PubMed] [Google Scholar] · DOI
- [31]Kumar M B, Ramadoss P, Reen R K, Vanden Heuvel J P, Perdew G H. J Biol Chem. 2001;276:42302–42310. doi: 10.1074/jbc.M104798200. [DOI] [PubMed] [Google Scholar] · DOI
- [32]Hoffman R E, Stehr-Green P A, Webb K B, Evans R G, Knutson A P, Schramm W F, Staak J L, Gibson B B, Steinberg K K. J Am Med Assoc. 1986;255:2031–2038. [PubMed] [Google Scholar]
- [33]Abbott B D, Birnbaum L S, Pratt R M. Teratology. 1987;35:329–334. doi: 10.1002/tera.1420350307. [DOI] [PubMed] [Google Scholar] · DOI
- [34]Natsume N, Kawai T, Le H. Cleft Palate Craniofac J. 1998;35:183–185. doi: 10.1597/1545-1569_1998_035_0183_tte_2.3.co_2. [DOI] [PubMed] [Google Scholar] · DOI
Cited by
Sorted by citations
Van den Berg, M., Birnbaum, L. S., Denison, M., De Vito, M., Farland, W., Feeley, M., Fiedler, H., Hakansson, H., Hanberg, A., Haws, L., et al. (2006) · Toxicological Sciences · doi:10.1093/toxsci/kfl055 · Cited by 3,785 · see citing works
Self-citationGodoy, P., Hewitt, N. J., Albrecht, U., Andersen, M. E., Ansari, N., Bhattacharya, S., Bode, J. G., Bolleyn, J., Borner, C., Böttger, J., et al. (2013) · Archives of Toxicology · doi:10.1007/s00204-013-1078-5 · Cited by 1,280 · see citing works
The aryl hydrocarbon receptor: multitasking in the immune system
Stockinger, B., Meglio, P. D., Gialitakis, M., & Duarte, J. H. (2014) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032713-120245 · Cited by 909 · see citing works
Denison, M. S., Soshilov, A. A., He, G., DeGroot, D. E., & Zhao, B. (2011) · Toxicological Sciences · doi:10.1093/toxsci/kfr218 · Cited by 748 · see citing works
Karchner, S. I., Franks, D. G., Kennedy, S. W., & Hahn, M. E. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509950103 · Cited by 207 · see citing works
Ligand Selectivity and Gene Regulation by the Human Aryl Hydrocarbon Receptor in Transgenic Mice
Flaveny, C. A., Murray, I. A., Chiaro, C. R., & Perdew, G. H. (2009) · Molecular Pharmacology · doi:10.1124/mol.109.054825 · Cited by 124 · see citing works
The Relationship between Typical Environmental Endocrine Disruptors and Kidney Disease
Zhang, X., Flaws, J. A., Spinella, M. J., & Irudayaraj, J. (2022) · Toxics · doi:10.3390/toxics11010032 · Cited by 63 · see citing works
Faber, S. C., Soshilov, A. A., Giani Tagliabue, S., Bonati, L., & Denison, M. S. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19092692 · Cited by 36 · see citing works
Species differences in renal development and associated developmental nephrotoxicity
Frazier, K. S. (2017) · Birth Defects Research · doi:10.1002/bdr2.1088 · Cited by 35 · see citing works
Kudo, K., Takeuchi, T., Murakami, Y., Ebina, M., & Kikuchi, H. (2009) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2009.06.003 · Cited by 25 · see citing works
Rodent Genetic Models of Ah Receptor Signaling
Wilson, R. H., & Bradfield, C. A. (2021) · Drug Metabolism Reviews · doi:10.1080/03602532.2021.1955916 · Cited by 16 · see citing works
“Interestingly, in early reports, the AhrHum allele was shown to be less sensitive to TCDD than the Ahrd allele (Moriguchi et al. 2003).”
BackgroundMethod
- Authors
- Moriguchi, T., Motohashi, H., Hosoya, T., Nakajima, O., Takahashi, S., Ohsako, S., Aoki, Y., Nishimura, N., Tohyama, C., Fujii-Kuriyama, Y., & Yamamoto, M.
- Affiliations
- University of Tsukuba (JP)
- Institute of Basic Medical Sciences, Center for Tsukuba Advanced Research Alliance, and Exploratory Research for Advanced Technology Environmental Response Project, University of Tsukuba, Tsukuba 305-8575, Japan; Environmental Health Sciences Division, National Institute for Environmental Studies, Onogawa, Tsukuba 305-8506 Japan; and Core Research for Evolutional Science and Technology, Japan Science and Technology Corporation, Kawaguchi 332-0012, Japan
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2003-05
- Volume
- 100
- Issue
- 10
- Pages
- 5652-5657
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC156256
- OpenAlex
- W2044544228
- Cited by
- 164
- References
- 1
- Citations by year
- 2026: 3 · 2025: 3 · 2024: 2 · 2023: 3 · 2022: 4 · 2021: 7 · 2020: 4 · 2019: 8 · 2018: 5 · 2017: 8 · 2016: 7 · 2015: 6 · 2014: 6 · 2013: 7 · 2012: 8
- FWCI
- 10.16
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Physical Sciences › Environmental Science › Health, Toxicology and Mutagenesis › Toxic Organic Pollutants Impact
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Physical Sciences › Environmental Science › Health, Toxicology and Mutagenesis › Effects and risks of endocrine disrupting chemicals
- Keywords
- aryl hydrocarbon receptor, dioxin toxicity, humanized mice, 2,3,7,8-tetrachlorodibenzo-p-dioxin, 3-methylcholanthrene, CYP1A1, CYP1A2, C57BL/6J mice, hydronephrosis, cleft palate
- MeSH terms
- Animals, Base Sequence, Dioxins, Female, Humans, Kidney, Methylcholanthrene, Mice, Transgenic, Palate, Pregnancy, Prenatal Exposure Delayed Effects, RNA, Messenger, DNA Primers, Receptors, Aryl Hydrocarbon, Reverse Transcriptase Polymerase Chain Reaction, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review